| | Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome. M Sata and M Ikebe J Clin Invest. 1996 December 15; 98(12): 2866–2873. PMCID: PMC507754 | | Is Cited by the Following Articles in this Archive: | The R403Q Myosin Mutation Implicated in Familial Hypertrophic Cardiomyopathy Causes Disorder at the Actomyosin Interface Niels Volkmann, HongJun Lui, Larnele Hazelwood, Kathleen M. Trybus, Susan Lowey, and Dorit Hanein PLoS ONE. 2007; 2(11): e1123. Published online 2007 November 7. doi: 10.1371/journal.pone.0001123.PMCID: PMC2040505 Myosin Dynamics on the Millisecond Time Scale Thomas P. Burghardt, Jimmy Yan Hu, and Katalin Ajtai Biophys Chem. Author manuscript; available in PMC 2008 August 11.PMCID: PMC2505346 Published in final edited form as: Biophys Chem. 2007 December; 131(1-3): 15–28. Published online 2007 September 11. doi: 10.1016/j.bpc.2007.08.008. Biological, Biochemical and Kinetic Effects of Mutations of the Cardiomyopathy-loop of Dictyostelium Myosin II: Importance of Ala400 Xiong Liu, Shi Shu, Mihály Kovács, and Edward D. Korn J Biol Chem. Author manuscript; available in PMC 2005 September 13.PMCID: PMC1201472 Published in final edited form as: J Biol Chem. 2005 July 22; 280(29): 26974–26983. Published online 2005 May 16. doi: 10.1074/jbc.M504453200. Heterologous expression of wild-type and mutant β-cardiac myosin changes the contractile kinetics of cultured mouse myotubes Gaynor Miller, Joanne Maycock, Ed White, Michelle Peckham, and Sarah Calaghan J Physiol. 2003 April 1; 548(Pt 1): 167–174. Published online 2003 February 7. doi: 10.1113/jphysiol.2002.031922.PMCID: PMC2342801 Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy Jil C. Tardiff, Timothy E. Hewett, Bradley M. Palmer, Charlotte Olsson, Stephen M. Factor, Russell L. Moore, Jeffrey Robbins, and Leslie A. Leinwand J Clin Invest. 1999 August 15; 104(4): 469–481. doi: 10.1172/JCI6067.PMCID: PMC408522 Altered cardiac excitation–contraction coupling in mutant mice with familial hypertrophic cardiomyopathy Wei Dong Gao, Nestor Gustavo Pérez, Christine E. Seidman, Jonathan G. Seidman, and Eduardo Marbán J Clin Invest. 1999 March 1; 103(5): 661–666. doi: 10.1172/JCI5220.PMCID: PMC408123 IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease P Skyllouriotis, M Skyllouriotis-Lazarou, S Natter, R Steiner, S Spitzauer, S Kapiotis, P Valent, A M Hirschl, S E Guber, G Laufer, G Wollenek, E Wolner, M Wimmer, and R Valenta Clin Exp Immunol. 1999 February; 115(2): 236–247. doi: 10.1046/j.1365-2249.1999.00807.x.PMCID: PMC1905170 Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the α cardiac myosin heavy chain gene Diane Fatkin, Michael E. Christe, Orlando Aristizabal, Bradley K. McConnell, Shardha Srinivasan, Frederick J. Schoen, Christine E. Seidman, Daniel H. Turnbull, and J.G. Seidman J Clin Invest. 1999 January 1; 103(1): 147–153. doi: 10.1172/JCI4631.PMCID: PMC407864 Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy. O Roopnarine and L A Leinwand Biophys J. 1998 December; 75(6): 3023–3030. PMCID: PMC1299973 Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: Insights into disease pathogenesis and troponin function H. Lee Sweeney, Huisheng S. Feng, Zhaouhui Yang, and Hugh Watkins Proc Natl Acad Sci U S A. 1998 November 24; 95(24): 14406–14410. PMCID: PMC24386 Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. L Oberst, G Zhao, J T Park, R Brugada, L H Michael, M L Entman, R Roberts, and A J Marian J Clin Invest. 1998 October 15; 102(8): 1498–1505. doi: 10.1172/JCI4088.PMCID: PMC508999 A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J C Tardiff, S M Factor, B D Tompkins, T E Hewett, B M Palmer, R L Moore, S Schwartz, J Robbins, and L A Leinwand J Clin Invest. 1998 June 15; 101(12): 2800–2811. doi: 10.1172/JCI2389.PMCID: PMC508871 | |
|